Clinical Trial Update: Antagonist-Elicited Cannabis Withdrawal [Phase 1]

View source ↗

Summary

Phase 1 trial investigating antagonist-elicited cannabis withdrawal in individuals with cannabis dependence; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Use Disorder

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cannabis, Dependence | Phase 1 | Status: COMPLETED